Atripla (Efavirenz/Emtricitabine/Tenofovir)

Atripla Information:

Buy Atripla

Atripla (Efavirenz/Emtricitabine/Tenofovir) is used alone or with other medications to treat HIV (human immunodeficiency virus) infection. It is an antiretroviral medicine that contains 3 active ingredients: Efavirenz, Emtricitabine, and Tenofovir disoproxil fumarate. Efavirenz belongs to the drug class called non-nucleoside reverse transcriptase inhibitor (NNRTI) while Emtricitabine and Tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors (NRTIs). These active ingredients work together to inhibit the action of reverse transcriptase, an enzyme that HIV uses to replicate its genetic material, thereby preventing the virus from making copies of itself. By targeting different steps in the HIV replication process, Atripla helps to suppress the virus, reduce its viral load in the body, slow down the progression of the infection, and prevent complications such as infections and cancer. This combination therapy is crucial in managing HIV and improving the quality of life for individuals living with the virus.

Generic Atripla from Canada

Canada Drugs Online is proud to serve you the generic Efavirenz/Emtricitabine/Tenofovir from Canada and India (Vonavir by Emcure). The brand version is not available. Please call us toll-free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other HIV/AIDS medications such as Atripla and Truvada.

CanadaDrugsOnline.com supplies only genuine Atripla from Canada shipped using Canadian packaging and genuine Atripla from Australia using Australian packaging. This Atripla is manufactured by Gilead Sciences, Inc., the worldwide manufacturer of Atripla. This offer is neither endorsed nor authorized by Gilead Sciences Inc. (the United States and Canadian distributor of Atripla). CanadaDrugsOnline.com has no affiliation whatsoever with Gilead Sciences Inc.

Atripla Side Effects:

Common mild side effects of this medication include dizziness, trouble sleeping, drowsiness, unusual dreams, trouble concentrating, tiredness, headache, diarrhea, small spots or freckles, or darkening of the palms of the hands and soles of the feet. Contact your doctor if these mild side effects persist or worsen.

Possible serious side effects of this medication include unexplained weight loss, severe tiredness, persistent muscle aches and weakness, persistent severe headaches, joint pain, numbness or tingling of the hands, feet, arms, and legs, abnormal vision changes, fever, chills, swollen lymph nodes, cough, non-healing skin sores, irritability, nervousness, heat intolerance, fast, pounding, or irregular heartbeat, bulging eyes, unusual growth in the neck known as a goiter, unsteadiness, loss of coordination, difficulty in swallowing, speaking, and chewing, trouble moving your eyes, depression, rare thoughts of suicide, strange thoughts, anxiety, angry behavior, hallucinations, confusion, a change in the amount of urine, unusual thirst, nausea, vomiting, abdominal and back pain, yellowness of the eyes and skin, dark urine, deep and rapid breathing, drowsiness, bone pain, easily broken bones, fainting, severe body itching, rash, swelling of your face, lips, tongue, or throat, and dizziness. Discontinue this medication and seek immediate medical attention if you observe these severe side effects. Additionally, inform your doctor about any other side effects not listed here.

The safety and efficacy of this medication have been established in different clinical trials. Being a fixed dose combination drug, it is found to be more effective in treating HIV infection than when its active ingredients are used independently. It is also safe to use and generally well tolerated by most individuals with few but uncommon side effects. The half-life of Atripla ranges from 10-55 hrs depending on its individual active components.

Atripla Directions:

Atripla comes in tablet form and is usually taken once daily, preferably at bedtime, on an empty stomach as directed by your doctor. The standard dosage is one tablet containing Efavirenz (600 mg), Emtricitabine (200 mg), and Tenofovir disoproxil fumarate (300 mg). Take Atripla at the same time each day to maintain a consistent level of the medication in your body. Try not to miss doses as consistency in timing and adherence is crucial for its effectiveness in treating HIV. Do not use more than the prescribed dose. Store Atripla at room temperature, away from moisture and heat, in its original container with the lid tightly closed. Also, keep it out of reach of children and pets.

Atripla Precautions:

Before taking this medication, ensure you inform your doctor about any past or current personal or family history of medical conditions, especially the following:
• Allergic reaction to Efavirenz, Emtricitabine, Tenofovir, other ingredients of Atripla, or any other medication;
• Autoimmune conditions such as Graves’ disease, Guillain-Barré syndrome;
• Bone problems such as osteoporosis;
• Chronic alcohol abuse;
• Depression;
• Electrolyte imbalance such as low levels of potassium in the blood;
• Heart disease, including abnormal heart rhythms;
• High blood cholesterol levels;
• Kidney disease;
• Liver disease, including hepatitis B infection;
• Mental or mood disorders such as depression;
• Pancreatic diseases such as pancreatitis;
• Seizure disorders

Avoid consuming alcohol and smoking cigarettes while taking this medication, as these substances can increase the risk of side effects. Atripla can cause dizziness, drowsiness, or difficulty in concentrating, so avoid driving or operating heavy machinery until you know how the medication affects you. Check with your doctor regularly while taking this medication, as regular blood tests may need to be done to monitor its effects in your body. This medication should be used with caution in elderly individuals as they are more prone to developing its side effects. It is not recommended for use in pregnant women or women planning to become pregnant. Women of reproductive age groups are advised to use appropriate methods of birth control while taking this medication and until after 12 weeks of stopping it. Consult your doctor immediately if you become pregnant while taking this medication. Women living with HIV infection should not breastfeed. Atripla is not recommended for use in individuals younger than 12 years or weighing less than 40 kg. Some medications can interact with the active ingredients in Atripla, leading to unwanted side effects or reduced effectiveness. Some of these drugs include:
• Antifungal drugs such as voriconazole;
• Antiviral agents such as adefovir, atazanavir;
• Benzodiazepines such as midazolam and triazolam;
• Other drugs that contain emtricitabine, lamivudine, or tenofovir

Therefore, you must inform your healthcare provider about all the medications, including herbal medications and supplements, that you are taking before starting Atripla to prevent drug interactions.